Award
NIH Reporter #3R01DA059234-04S1
Hemp-derived Cannabidiol for the treatment of cannabis use disorder in concentrate users: A double-blind placebo-controlled randomized trial
Recipient
Not specified
Award Amount
$98,952.00
Ceiling
$98,952.00
Awarded
August 05, 2026
Identifier
3R01DA059234-04S1
This award funds a clinical trial studying the effectiveness of hemp-derived cannabidiol in treating cannabis use disorder among concentrate users, involving 150 adults over 8 weeks.
Description
A randomized controlled trial to evaluate hemp-derived CBD with and without THC to assess reduction in THC use, cannabis use disorder symptoms, and withdrawal symptoms in 150 adult participants over an 8-week protocol, with psychological support for cannabis use reduction.